Real-world performance of faricimab for neovascular age-related macular degeneration and diabetic macular edema: experience from the BrazilRetNet multicenter study. Report 1.

Kniggendorf V, Silveira TC, Costa VDM, Soriano DS, Regatieri CV, Sugai RF, Bordon A, Nutels GS, Peixoto AL, Moreira-Neto CA, Miranda JVC, Nehemy MB, Damico FM, Zacharias LC, Lavinsky D, Machado CG, Veloso CED, Cyrino FV, Cella W, Roisman L, Brasil OF, Andrade GC, Stefanini F, Malerbi FK, Penha FM, BrazilRetNet, Brazilian Retinal Research Network

Open source

DOI: 10.1186/s40942-026-00860-z
Published: 2026 Apr 22
Container: International journal of retina and vitreous
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1186/s40942-026-00860-z,
  title = {Real-world performance of faricimab for neovascular age-related macular degeneration and diabetic macular edema: experience from the BrazilRetNet multicenter study. Report 1.},
  author = {Kniggendorf V and Silveira TC and Costa VDM and Soriano DS and Regatieri CV and Sugai RF and Bordon A and Nutels GS and Peixoto AL and Moreira-Neto CA and Miranda JVC and Nehemy MB and Damico FM and Zacharias LC and Lavinsky D and Machado CG and Veloso CED and Cyrino FV and Cella W and Roisman L and Brasil OF and Andrade GC and Stefanini F and Malerbi FK and Penha FM and BrazilRetNet, Brazilian Retinal Research Network},
  year = {2026},
  journal = {International journal of retina and vitreous},
  doi = {10.1186/s40942-026-00860-z},
  url = {https://doi.org/10.1186/s40942-026-00860-z}
}

RIS

TY  - JOUR
TI  - Real-world performance of faricimab for neovascular age-related macular degeneration and diabetic macular edema: experience from the BrazilRetNet multicenter study. Report 1.
AU  - Kniggendorf V
AU  - Silveira TC
AU  - Costa VDM
AU  - Soriano DS
AU  - Regatieri CV
AU  - Sugai RF
AU  - Bordon A
AU  - Nutels GS
AU  - Peixoto AL
AU  - Moreira-Neto CA
AU  - Miranda JVC
AU  - Nehemy MB
AU  - Damico FM
AU  - Zacharias LC
AU  - Lavinsky D
AU  - Machado CG
AU  - Veloso CED
AU  - Cyrino FV
AU  - Cella W
AU  - Roisman L
AU  - Brasil OF
AU  - Andrade GC
AU  - Stefanini F
AU  - Malerbi FK
AU  - Penha FM
AU  - BrazilRetNet, Brazilian Retinal Research Network
PY  - 2026
JO  - International journal of retina and vitreous
DO  - 10.1186/s40942-026-00860-z
UR  - https://doi.org/10.1186/s40942-026-00860-z
ER  -

APA

V, K., TC, S., VDM, C., DS, S., CV, R., RF, S., A, B., GS, N., AL, P., CA, M., JVC, M., MB, N., FM, D., LC, Z., D, L., CG, M., CED, V., FV, C., W, C., L, R., OF, B., GC, A., F, S., FK, M., FM, P., & Network, B. B. R. R. (2026). Real-world performance of faricimab for neovascular age-related macular degeneration and diabetic macular edema: experience from the BrazilRetNet multicenter study. Report 1.. International journal of retina and vitreous. https://doi.org/10.1186/s40942-026-00860-z

Source records

pubmed · retrieved 2026-09-27T01:27:38.072Z